ArticleInternational journal of nanomedicine2020

Enhancing Anti-Tumor Activity of Sorafenib Mesoporous Silica Nanomatrix in Metastatic Breast Tumor and Hepatocellular Carcinoma via the Co-Administration with Flufenamic Acid.

Zhuo-Yue Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.